Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Indo Amines Ltd

INDOAMIN
NSE
113.56
0.24%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Indo Amines Ltd

INDOAMIN
NSE
113.56
0.24%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
824Cr
Close
Close Price
113.56
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
11.66
PS
Price To Sales
0.73
Revenue
Revenue
1,127Cr
Rev Gr TTM
Revenue Growth TTM
7.76%
PAT Gr TTM
PAT Growth TTM
32.02%
Peer Comparison
How does INDOAMIN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
INDOAMIN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
235244253194253265269259285288277277
Growth YoY
Revenue Growth YoY%
9.7-5.74.9-8.18.08.86.433.512.78.62.97.2
Expenses
ExpensesCr
204222233173236237245234261256245252
Operating Profit
Operating ProfitCr
312220211728242425313225
OPM
OPM%
13.28.98.010.76.910.48.99.48.710.911.59.1
Other Income
Other IncomeCr
2452585201652
Interest Expense
Interest ExpenseCr
566655666666
Depreciation
DepreciationCr
443444444555
PBT
PBTCr
231716131326191715362616
Tax
TaxCr
645336653774
PAT
PATCr
17121210919141112291812
Growth YoY
PAT Growth YoY%
644.844.0143.5-5.7-46.858.915.615.229.949.431.35.0
NPM
NPM%
7.35.04.75.13.67.35.14.44.210.06.54.3
EPS
EPS
2.41.71.81.31.32.71.91.61.73.92.51.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
2342532853555284795417869459431,0791,127
Growth
Revenue Growth%
6.17.912.624.948.6-9.312.945.420.2-0.214.34.5
Expenses
ExpensesCr
2122222493144734374797348588639781,014
Operating Profit
Operating ProfitCr
22303641554261528780101113
OPM
OPM%
9.611.912.611.510.58.811.36.69.28.59.410.1
Other Income
Other IncomeCr
1134778104161523
Interest Expense
Interest ExpenseCr
5448101191417222224
Depreciation
DepreciationCr
101212121520111417151720
PBT
PBTCr
81523253818493557587793
Tax
TaxCr
3679136121116152122
PAT
PATCr
5916162513372341435671
Growth
PAT Growth%
-8.873.278.2-1.457.9-49.2192.5-38.577.45.130.126.4
NPM
NPM%
2.23.65.74.54.82.76.92.94.34.55.26.3
EPS
EPS
0.81.42.52.33.61.75.33.35.85.97.79.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
333333333333353535363636
Reserves
ReservesCr
1217364890100127152190228281324
Current Liabilities
Current LiabilitiesCr
101102127143192189236314309304372391
Non Current Liabilities
Non Current LiabilitiesCr
101517222938545262678991
Total Liabilities
Total LiabilitiesCr
155167213246346362453554597635779843
Current Assets
Current AssetsCr
99112102159209211265340373396471496
Non Current Assets
Non Current AssetsCr
565511187137150189214225239308348
Total Assets
Total AssetsCr
155167213246346362453554597635779843

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
231915827395615207035
Investing Cash Flow
Investing Cash FlowCr
-14-10-23-21-43-36-50-39-30-27-82
Financing Cash Flow
Financing Cash FlowCr
-9-971617-3-1324-4142
Net Cash Flow
Net Cash FlowCr
10-132059-52-5
Free Cash Flow
Free Cash FlowCr
69-2-14-1626-24-1044-48
CFO To PAT
CFO To PAT%
447.5210.890.148.5108.8302.4149.967.149.8162.663.4
CFO To EBITDA
CFO To EBITDA%
104.663.640.619.049.792.091.629.623.487.335.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6612323828431495311655548787836
Price To Earnings
Price To Earnings
13.815.014.917.812.47.48.328.713.618.915.1
Price To Sales
Price To Sales
0.30.50.80.80.60.20.60.80.60.80.8
Price To Book
Price To Book
1.52.53.53.62.60.71.93.52.53.12.6
EV To EBITDA
EV To EBITDA
4.85.48.18.87.75.17.416.18.712.310.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.135.434.033.330.333.035.130.830.630.032.2
OPM
OPM%
9.611.912.611.510.58.811.36.69.28.59.4
NPM
NPM%
2.23.65.74.54.82.76.92.94.34.55.2
ROCE
ROCE%
14.719.521.320.219.711.218.112.316.216.716.5
ROE
ROE%
11.718.223.419.820.59.723.012.318.116.317.6
ROA
ROA%
3.45.57.66.57.33.58.34.26.86.87.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Indo Amines Limited (**IAL**), established in **1994**, is a premier South Asian manufacturer and global supplier of **Fine, Specialty, and Performance Chemicals**. With a product portfolio exceeding **500 items** and a presence in over **70 countries**, IAL operates as a vertically integrated player. The company leverages indigenous manufacturing technology and **DSIR-approved** in-house R&D to reduce dependency on imports, aligning with the "**Atmanirbhar Bharat**" initiative. --- ### **Core Market Segments and Global Footprint** IAL serves a diverse array of high-growth end-user industries through five primary chemical segments. Exports are a critical pillar of the business, accounting for approximately **51.66%** of total production. * **Primary Segments:** Fine Chemicals, Specialty Chemicals, Performance Chemicals, Perfumery Chemicals, and Active Pharmaceutical Ingredients (**APIs**). * **Key End-User Industries:** Pharmaceuticals, Agrochemicals, Fertilizers, Petrochemicals, Road Construction, Pesticides, Dyes & Intermediates, and Personal Care. * **Geographic Reach:** Operations span India, USA, Europe, Malaysia, China, Australia, and Japan. * **Global Subsidiaries:** * **Indo Amines Americas LLC** (USA) * **Indo Amines (Europe) Ltd** (Europe) * **Indo Amines (Malaysia) SDN BHD** (Malaysia) * **Indo Amines (Changzhou) Co. Ltd** (China) * **Indo Speciality Chemicals Pvt Ltd** (India - Reclassified as an **Associate** in **March 2026**). --- ### **Manufacturing Infrastructure and Capacity Scale-up** IAL maintains a robust production footprint with a total installed capacity of **110,000 MTPA**. The company has aggressively expanded its capacity between **2023 and 2025** to meet rising global demand. | Facility Location | Key Features & Recent Developments | | :--- | :--- | | **Dhule, Maharashtra** | Launched **Morpholine and Derivatives** in **April 2025**; features **ZLD** units. | | **Mahad, Maharashtra** | Key administrative unit; received **Environmental Clearance** for capacity enhancement. | | **Baroda, Gujarat** | Focuses on **Fine & Specialty Chemicals**; includes **EO plant** automation. | | **Badlapur, Maharashtra** | Features **Biomass-fixed thermic fluid heaters** to replace furnace oil. | | **Dombivli, Maharashtra** | Registered Office; **W-35** plant underwent restoration following a **2024** fire. | **Recent Product Commercialization (Monthly Capacities):** * **ADMA-8/10** (N, N-dimethyl Octanamide/Decanamide): **350 MT** (Dhule) * **Benzoguanamine**, **CAMPA**, and **THIEC**: **300 MT** each (Mahad/Badlapur/Dhule) * **OCG & PGG** (O-Cresyl / Phenyl Glycityl Ether): **250 MT** (W-38 Unit) * **EHG** (Ethyl Hexyl Glycerin): **200 MT** (Mahad) * **Specialty Amines (Bis-DAPA, DBAPA, Bis-MAPA)**: **200 MT** each (Sigma Unit) --- ### **Strategic Consolidation and Corporate Restructuring** The company is executing a multi-pronged strategy to streamline operations, enhance synergies, and incentivize its workforce. * **Amalgamation with Pious Engineering:** Completed in **November 2024** (effective **Jan 1, 2023**). IAL issued **1,890,000** equity shares to integrate engineering and fabrication capabilities, reducing administrative costs and strengthening the balance sheet. * **Promoter Reclassification:** In **2024-2025**, several members were reclassified from 'Promoter' to 'Public', increasing public shareholding from **33.24%** to **42.74%**. * **Asset Monetization:** Disposed of the **Rabale Unit** (Navi Mumbai) in **December 2023** and transferred leasehold land rights in **Q1 FY 2025-26** for **₹6 crore**, netting a gain of **₹5.95 crore**. * **Indo ESOP Plan 2025:** Introduced to grant up to **725,000** stock options to employees, with a vesting period of **1 to 5 years**. * **Global Partnerships:** Signed a Sales and Technology Agreement with **Indo Europe Additive SL (Spain)** in **September 2024** to expand the performance chemicals portfolio. --- ### **Financial Performance and Credit Profile** IAL has demonstrated a consistent upward trajectory in revenue and profitability, supported by disciplined debt management. **Consolidated Financial Summary:** | Metric | FY 2021-22 | FY 2022-23 | FY 2023-24 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **₹786.04 Cr** | **₹945.01 Cr** | **₹959.78 Cr** | | **Profit Before Tax** | **₹34.51 Cr** | **₹56.79 Cr** | **₹58.05 Cr** | | **Profit After Tax** | **₹23.03 Cr** | **₹40.89 Cr** | **₹42.81 Cr** | **Credit and Capital Strength:** * **Credit Rating Upgrade:** In **April 2025**, **CRISIL** upgraded IAL to **CRISIL A-/Stable** (Long Term) and **CRISIL A2+** (Short Term). * **Borrowing Capacity:** Shareholders approved doubling the borrowing limit from **₹500 Crores** to **₹1,000 Crores** in **January 2025** to fund expansion. * **Dividend:** Recommended a **10%** final dividend (**₹0.50 per share**) for **FY 2023-24**. --- ### **R&D, Innovation, and Sustainability** IAL is transitioning toward a high-value, low-carbon business model. * **R&D Investment:** Investing **₹75 Crores** in continuous chemical synthesis and **decarboxylative ketonization** to scale up **Ketonic products**. * **Climate Goals:** Committed to becoming **climate neutral by 2050**. * **Green Initiatives:** * **95%** of steam requirements are met using **Agro-mass briquettes**. * Implementation of **Zero Liquid Discharge (ZLD)** across all units. * Transition from furnace oil to **LPG** and **Biomass-fixed thermic fluid heaters**. * **Certifications:** Holds **ISO 9001:2015**, **ISO 14001**, **ISO 45001**, and **ISO 22000**. Awarded **'Three Star Export House'** status in **July 2024**. --- ### **Risk Management and Business Continuity** IAL employs a structured framework to mitigate operational, regulatory, and financial risks. * **Operational Resilience:** Following a fire at the **W-35 Dombivli** unit in **June 2024** (inventory loss of **₹2.6 crore**), production was successfully shifted to alternate sites. The loss is being recovered via a **corporate insurance program**. * **Regulatory Compliance:** Actively managing environmental norms. While the **Vadodara** unit faced a temporary closure notice in **2023**, the company has since reinforced its monsoon action plans and compliance protocols. * **Market & Forex Risk:** IAL uses a **natural hedge** through its high export volume and utilizes **forward contracts** for USD exposure above predefined thresholds. It avoids speculative derivative trading. * **Supply Chain:** To counter geopolitical volatility and competition from **Chinese producers**, IAL focuses on **process development** and **cost competitiveness** through its in-house R&D.